tiprankstipranks
Pharming Group (PHAR)
NASDAQ:PHAR
US Market
PHAR
Pharming Group
RESEARCH TOOLSreports
Want to see PHAR full AI Analyst Report?

Pharming Group (PHAR) Ratios

237 Followers

Pharming Group Ratios

PHAR's free cash flow for Q2 2026 was €0.84. For the 2026 fiscal year, PHAR's free cash flow was decreased by € and operating cash flow was €0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.01 2.59 3.77 4.06 4.65
Quick Ratio
 2.31 2.03 3.02 3.33 3.94
Cash Ratio
 1.70 1.26 0.74 0.79 3.47
Solvency Ratio
 0.10 0.06 0.02 0.02 0.12
Operating Cash Flow Ratio
 0.33 0.47 -0.02 -0.22 0.38
Short-Term Operating Cash Flow Coverage
 5.71 10.25 -0.42 -9.49 12.70
Net Current Asset Value
€ 69.72M$ 76.58M$ 103.05M$ 72.27M$ 56.34M
Leverage Ratios
Debt-to-Assets Ratio
 0.27 0.23 0.28 0.37 0.39
Debt-to-Equity Ratio
 0.49 0.42 0.51 0.78 0.81
Debt-to-Capital Ratio
 0.33 0.29 0.34 0.44 0.45
Long-Term Debt-to-Capital Ratio
 0.29 0.25 0.26 0.38 0.39
Financial Leverage Ratio
 1.82 1.80 1.81 2.12 2.08
Debt Service Coverage Ratio
 0.02 1.52 1.00 1.46 4.52
Interest Coverage Ratio
 <0.01 1.95 -0.99 -0.90 3.40
Debt to Market Cap
 0.14 0.08 0.12 0.18 0.15
Interest Debt Per Share
 25.21 1.77 1.82 2.70 2.08
Net Debt to EBITDA
 -0.88 -0.87 3.52 11.12 -1.21
Profitability Margins
Gross Profit Margin
86.50%87.90%88.09%89.72%91.46%
EBIT Margin
6.46%6.27%0.08%-2.47%9.89%
EBITDA Margin
9.73%9.25%5.49%4.03%16.31%
Operating Profit Margin
4.00%5.55%-2.90%-2.20%8.87%
Pretax Profit Margin
4.35%3.42%-2.86%-4.90%7.29%
Net Profit Margin
2.57%0.76%-3.98%-4.30%6.65%
Continuous Operations Profit Margin
2.57%0.67%-3.98%-4.30%6.65%
Net Income Per EBT
59.06%22.19%139.44%87.81%91.24%
EBT Per EBIT
108.79%61.52%98.50%222.98%82.20%
Return on Assets (ROA)
2.01%0.57%-2.96%-2.28%3.21%
Return on Equity (ROE)
3.52%1.03%-5.36%-4.82%6.68%
Return on Capital Employed (ROCE)
3.91%5.44%-2.64%-1.40%4.98%
Return on Invested Capital (ROIC)
2.24%1.05%-2.59%-1.21%4.48%
Return on Tangible Assets
2.77%0.78%-3.49%-2.69%3.90%
Earnings Yield
1.20%0.23%-1.77%-1.40%1.50%
Efficiency Ratios
Receivables Turnover
 6.43 6.88 5.92 5.76 8.12
Payables Turnover
 0.60 0.43 3.50 1.57 2.01
Inventory Turnover
 0.76 0.70 0.64 0.44 0.41
Fixed Asset Turnover
 17.88 15.70 12.76 7.33 5.25
Asset Turnover
 0.78 0.75 0.74 0.53 0.48
Working Capital Turnover Ratio
 1.98 1.90 1.37 1.08 0.98
Cash Conversion Cycle
 -67.90 -275.71 532.02 653.18 742.73
Days of Sales Outstanding
 56.77 53.07 61.62 63.41 44.97
Days of Inventory Outstanding
 482.88 520.48 574.57 821.73 879.68
Days of Payables Outstanding
 607.56 849.26 104.17 231.95 181.92
Operating Cycle
 539.66 573.55 636.19 885.13 924.65
Cash Flow Ratios
Operating Cash Flow Per Share
 0.44 0.77 -0.03 -0.26 0.27
Free Cash Flow Per Share
 0.43 0.76 -0.04 -0.29 0.25
CapEx Per Share
 <0.01 0.01 0.01 0.02 0.02
Free Cash Flow to Operating Cash Flow
 0.98 0.99 1.44 1.08 0.91
Dividend Paid and CapEx Coverage Ratio
 47.17 72.46 -2.26 -11.82 11.36
Capital Expenditure Coverage Ratio
 47.17 72.46 -2.26 -11.82 11.36
Operating Cash Flow Coverage Ratio
 0.25 0.47 -0.02 -0.10 0.13
Operating Cash Flow to Sales Ratio
 0.09 0.15 >-0.01 -0.07 0.11
Free Cash Flow Yield
3.90%4.28%-0.39%-2.50%2.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 75.24 441.75 -57.22 -71.20 66.58
Price-to-Sales (P/S) Ratio
 2.14 3.35 2.26 3.06 4.43
Price-to-Book (P/B) Ratio
 3.05 4.55 3.03 3.43 4.45
Price-to-Free Cash Flow (P/FCF) Ratio
 25.61 23.36 -258.67 -40.02 44.45
Price-to-Operating Cash Flow Ratio
 25.07 23.03 -373.38 -43.40 40.54
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -3.60 -2.68 0.38 -3.92
Price-to-Fair Value
 3.05 4.55 3.03 3.43 4.45
Enterprise Value Multiple
 21.07 35.36 44.60 87.15 25.94
Enterprise Value
 751.36M 1.23B 753.42M 860.79M 869.82M
EV to EBITDA
 21.07 35.36 44.60 87.15 25.94
EV to Sales
 2.05 3.27 2.45 3.51 4.23
EV to Free Cash Flow
 24.58 22.80 -280.82 -45.87 42.47
EV to Operating Cash Flow
 24.06 22.48 -405.34 -49.75 38.73
Tangible Book Value Per Share
 3.63 1.98 2.40 2.25 1.57
Shareholders’ Equity Per Share
 3.63 3.88 3.32 3.33 2.48
Tax and Other Ratios
Effective Tax Rate
 0.41 0.80 -0.39 0.12 0.09
Revenue Per Share
 5.17 5.27 4.47 3.73 2.49
Net Income Per Share
 0.13 0.04 -0.18 -0.16 0.17
Tax Burden
 0.59 0.22 1.39 0.88 0.91
Interest Burden
 0.67 0.55 -34.66 1.99 0.74
Research & Development to Revenue
 0.31 0.27 0.28 0.28 0.26
SG&A to Revenue
 164.91 0.31 0.33 0.33 0.30
Stock-Based Compensation to Revenue
 0.04 0.04 0.04 0.04 0.03
Income Quality
 2.15 4.26 0.21 1.44 1.50